ADAR1 Capital Management »

Rhythm Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $534k 13k 41.06
2024-03-31 $537k 12k 43.33
2023-12-31 $46k 1.0k 45.97

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Perceptive Advisors
Vanguard Group
NEA Management Company
Frazier Life Sciences Management
State Street Corporation
Federated Investors
Polar Capital Holdings
Driehaus Capital Management
Geode Capital Management
Rock Springs Capital Management

View all funds holding Rhythm Pharmaceuticals